The use of proteasome inhibitors to sensitize GC-resistant ALL cells was supported by detecting that high expression of valosin-containing protein (VCP), a member of the ubiquitin proteasome degradation system (UPS), is associated with poor response to prednisolone treatment in childhood ALL patients (Lauten et al. 2006). This evidence concerns the gene VCP and acute lymphoblastic leukemia.